MRS. IONICA E LAZAR NP
Prescription History 1619093721
Nurse Practitioner - Family in New York, NY

Active since March 21, 2007PECOS Enrolled
161 MADISON AVE, SUITE 10E, NEW YORK, NY 10016(646) 637-3322(212) 353-1915 Get Directions

NPPES record last updated: March 24, 2015. Verified against the NPPES registry weekly; last sync: October 25, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. IONICA E LAZAR NP, an active Family specialist practicing in New York, NY. Our medical registry currently tracks 10 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 524 documented patient claims. Among these therapy options, the most frequently utilized medication is Auryxia, which accounts for 142 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

10
Medications
524
Total Claims
660
30-Day Fills
Auryxia
Most Prescribed · 142 claims
View details
10 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by MRS. IONICA E LAZAR NP in 2024, with prescription volumes, average cost per fill, and NY state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other NY PrescribersVs. NY Avg

About Auryxia: Ferric citrate is used to lower high blood phosphate levels in people who are on dialysis due to severe kidney disease. Show more ▾

Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and may decrease the risk of heart disease and strokes that can result from high phosphate levels. This medication works by binding to phosphate in the foods you eat. The phosphate then passes out of your body in your stool. Ferric citrate is a form of iron. This medication is also used to treat low blood levels of iron (anemia) in people with long-term kidney disease who are not on dialysis. Iron is an important mineral that your body needs to produce red blood cells and keep you in good health.

In 2024, this provider wrote 142 Medicare prescriptions for Auryxia, about 6.1 times the volume of the typical New York prescriber of this medication (23.4). Medicare paid an average of $1,374.58 per fill, versus $1,652.34 statewide.

How often this provider prescribes it

This provider
142
NY average
23.4

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,374.58
NY average
$1,652.34

This provider's average cost per fill is below the NY average for this medication.

152
30-Day Fills
standardized to 30-day supplies
4,542
Days of Medication
total across all patients in 2024

About Sevelamer Carbonate: Sevelamer is used to lower high blood phosphorus (phosphate) levels in patients who are on dialysis due to severe kidney disease. Show more ▾

Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and possibly decrease the risk of heart disease and strokes that can result from high phosphate levels. Sevelamer works by holding onto phosphate from the diet so that it can pass out of your body. A polymeric amine that binds phosphate and is used to treat HYPERPHOSPHATEMIA in patients with kidney disease.

In 2024, this provider wrote 92 Medicare prescriptions for Sevelamer Carbonate, about 2.4 times the volume of the typical New York prescriber of this medication (37.6). Medicare paid an average of $211.47 per fill, versus $180.90 statewide.

How often this provider prescribes it

This provider
92
NY average
37.6

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$211.47
NY average
$180.90

Gross Part D cost per fill; not the patient's out-of-pocket price.

142
30-Day Fills
standardized to 30-day supplies
4,223
Days of Medication
total across all patients in 2024

About Velphoro: Sucroferric oxyhydroxide is used to lower high blood phosphate levels in people who are on dialysis due to severe kidney disease. Show more ▾

Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and may decrease the risk of heart disease and strokes that can result from high phosphate levels. Sucroferric oxyhydroxide contains a form of iron which is not absorbed by your body. It works by binding to phosphate in your diet. The phosphate then passes out of your body in your stool. An oral phosphate binder for treatment of hyperphosphatemia.

In 2024, this provider wrote 61 Medicare prescriptions for Velphoro, about 2.1 times the volume of the typical New York prescriber of this medication (28.5). Medicare paid an average of $2,765.13 per fill, versus $2,620.94 statewide.

How often this provider prescribes it

This provider
61
NY average
28.5

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,765.13
NY average
$2,620.94

Gross Part D cost per fill; not the patient's out-of-pocket price.

64.5
30-Day Fills
standardized to 30-day supplies
1,902
Days of Medication
total across all patients in 2024

About Calcium Acetate: Calcium acetate is used to prevent high blood phosphate levels in patients who are on dialysis due to severe kidney disease. Show more ▾

Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and possibly decrease the risk of heart disease and strokes that can result from high phosphate levels. Calcium acetate is a natural mineral that works by holding onto phosphate from the diet so that it can pass out of your body. A principal compound used as phosphate binders in patients with chronic renal failure; used like sevelamer.

In 2024, this provider wrote 49 Medicare prescriptions for Calcium Acetate, about 1.6 times the volume of the typical New York prescriber of this medication (30.8). Medicare paid an average of $67.79 per fill, versus $66.61 statewide.

How often this provider prescribes it

This provider
49
NY average
30.8

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$67.79
NY average
$66.61

Gross Part D cost per fill; not the patient's out-of-pocket price.

67
30-Day Fills
standardized to 30-day supplies
2,010
Days of Medication
total across all patients in 2024

About Xphozah: Tenapanor is used to lower high blood phosphate levels in people who are on dialysis due to long-term kidney disease. Show more ▾

Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. This medication works by decreasing how much phosphate your body absorbs from the foods you eat. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and may decrease the risk of heart disease and strokes that can result from high phosphate levels. This medication must not be used by children younger than 6 years due to the risk for harm (especially serious dehydration). Inhibits intestinal sodium-hydrogen exchanger 3.

In 2024, this provider wrote 48 Medicare prescriptions for Xphozah, about 2 times the volume of the typical New York prescriber of this medication (24.2). Medicare paid an average of $2,771.63 per fill, versus $3,033.20 statewide.

How often this provider prescribes it

This provider
48
NY average
24.2

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,771.63
NY average
$3,033.20

This provider's average cost per fill is below the NY average for this medication.

48
30-Day Fills
standardized to 30-day supplies
1,428
Days of Medication
total across all patients in 2024

About Renvela: Sevelamer is used to lower high blood phosphorus (phosphate) levels in patients who are on dialysis due to severe kidney disease. Show more ▾

Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and possibly decrease the risk of heart disease and strokes that can result from high phosphate levels. Sevelamer works by holding onto phosphate from the diet so that it can pass out of your body. A polymeric amine that binds phosphate and is used to treat HYPERPHOSPHATEMIA in patients with kidney disease.

In 2024, this provider wrote 35 Medicare prescriptions for Renvela, about 2.2 times the volume of the typical New York prescriber of this medication (15.7). Medicare paid an average of $2,449.02 per fill, versus $1,197.89 statewide.

How often this provider prescribes it

This provider
35
NY average
15.7

This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,449.02
NY average
$1,197.89

Gross Part D cost per fill; not the patient's out-of-pocket price.

53.5
30-Day Fills
standardized to 30-day supplies
1,598
Days of Medication
total across all patients in 2024

In 2024, this provider wrote 32 Medicare prescriptions for Clinolipid, about 78% of the volume of the typical New York prescriber of this medication (40.9). Medicare paid an average of $201.00 per fill, versus $297.56 statewide.

How often this provider prescribes it

This provider
32
NY average
40.9

This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$201.00
NY average
$297.56

This provider's average cost per fill is below the NY average for this medication.

32
30-Day Fills
standardized to 30-day supplies
213
Days of Medication
total across all patients in 2024

About Nifedipine Er: Nifedipine is used alone or in combination with other drugs to treat high blood pressure (hypertension). Show more ▾

Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication is also used for certain types of chest pain (angina). It may help increase your ability to exercise and decrease the frequency of chest pain attacks. It should not be used to treat chest pain when it occurs. Use other medications (such as sublingual nitroglycerin) to relieve attacks of chest pain as directed by your doctor. Consult your doctor or pharmacist for more details. This medication is known as a calcium channel blocker. It works by relaxing and widening blood vessels so blood can flow more easily. A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

In 2024, this provider wrote 24 Medicare prescriptions for Nifedipine Er, about half the volume of the typical New York prescriber of this medication (40.5). Medicare paid an average of $24.34 per fill, versus $23.72 statewide.

How often this provider prescribes it

This provider
24
NY average
40.5

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$24.34
NY average
$23.72

Gross Part D cost per fill; not the patient's out-of-pocket price.

44
30-Day Fills
standardized to 30-day supplies
1,320
Days of Medication
total across all patients in 2024

In 2024, this provider wrote 22 Medicare prescriptions for Prosol, about a third of the volume of the typical New York prescriber of this medication (54.1). Medicare paid an average of $108.71 per fill, versus $163.33 statewide.

How often this provider prescribes it

This provider
22
NY average
54.1

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$108.71
NY average
$163.33

This provider's average cost per fill is below the NY average for this medication.

22
30-Day Fills
standardized to 30-day supplies
142
Days of Medication
total across all patients in 2024

About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾

It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

In 2024, this provider wrote 19 Medicare prescriptions for Atorvastatin Calcium, about 10% of the volume of the typical New York prescriber of this medication (194.9). Medicare paid an average of $11.89 per fill, versus $10.41 statewide.

How often this provider prescribes it

This provider
19
NY average
194.9

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$11.89
NY average
$10.41

Gross Part D cost per fill; not the patient's out-of-pocket price.

35
30-Day Fills
standardized to 30-day supplies
1,050
Days of Medication
total across all patients in 2024
No medications match the current filters.
= the 5 medications this provider prescribes most.▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average NY prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the NY average cost per fill.

About this data. The prescription history for MRS. IONICA E LAZAR NP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this New York, NY practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NY prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.